These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35218452)

  • 1. Women's Perceptions of HIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa.
    Bergam S; Harrison AD; Benghu N; Khumalo S; Tesfay N; Exner T; Miller L; Dolezal C; Hanass-Hancock J; Hoffman S
    AIDS Behav; 2022 Sep; 26(9):2881-2890. PubMed ID: 35218452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini.
    Bjertrup PJ; Mmema N; Dlamini V; Ciglenecki I; Mpala Q; Matse S; Kerschberger B; Wringe A
    BMC Public Health; 2021 Apr; 21(1):727. PubMed ID: 33853575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
    J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.
    Duby Z; Bunce B; Fowler C; Jonas K; Bergh K; Govindasamy D; Wagner C; Mathews C
    AIDS Behav; 2023 Jan; 27(1):134-149. PubMed ID: 35793053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
    Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
    BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "You tell him that 'baby, I am protecting myself'": Women's agency and constraint around willingness to use pre-exposure prophylaxis in the Masibambane Study.
    Harrison A; Bhengu N; Miller L; Exner T; Tesfay N; Magutshwa S; Khumalo S; Bergam S; Hoffman S; Hanass-Hancock J
    Womens Health (Lond); 2022; 18():17455057221087117. PubMed ID: 35306944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a conceptual framework on PrEP stigma among adolescent girls and young women in sub-Saharan Africa.
    Hartmann M; Nyblade L; Otticha S; Marton T; Agot K; Roberts ST
    J Int AIDS Soc; 2024 Feb; 27(2):e26213. PubMed ID: 38379129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
    Cholo FA; Dada S; Martin CE; Mullick S
    J Int AIDS Soc; 2024 May; 27(5):e26249. PubMed ID: 38695102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
    de Vos L; Mudzingwa EK; Fynn L; Atujuna M; Mugore M; Gandhi M; Celum C; Hosek S; Bekker LG; Daniels J; Medina-Marino A
    J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative Analysis Using Social Maps to Explore Young Women's Experiences With Social Support of their Oral PrEP Use in Kenya and South Africa.
    Katz AWK; Roberts S; Rousseau E; Khoza MN; Mogaka F; Bukusi E; Delany-Moretlwe S; Bekker LG; Morton JF; Johnson R; Baeten JM; Celum C; van der Straten A
    J Assoc Nurses AIDS Care; 2023 Jan-Feb 01; 34(1):45-57. PubMed ID: 36170124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
    Dietrich JJ; Ahmed N; Tshabalala G; Wu M; Mulaudzi M; Hornschuh S; Atujuna M; Muhumuza R; Ssemata AS; Stranix-Chibanda L; Nematadzira T; Bekker LG; Martinson N; Seeley J; Fox J
    PLoS One; 2023; 18(6):e0287627. PubMed ID: 37384792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Qualitative Exploration of Various Stigmas Impacting HIV Pre-Exposure Prophylaxis (PrEP) Uptake Among African American Young Adults.
    Kerr J; Ayangeakaa S; Bullock NAA; Burton K; Combs R; Harris L; Sterrett-Hong E; Rozema I; Sears J; Northington T
    Fam Community Health; 2022 Oct-Dec 01; 45(4):218-227. PubMed ID: 35985022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
    AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's perspectives on barriers to potential PrEP uptake for HIV prevention: HIV risk assessment, relationship dynamics and stigma.
    O'Malley TL; Krier SE; Bainbridge M; Hawk ME; Egan JE; Burke JG
    Cult Health Sex; 2023 Jun; 25(6):776-790. PubMed ID: 35839305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PrEPARE Pretoria Project: protocol for a cluster-randomized factorial-design trial to prevent HIV with PrEP among adolescent girls and young women in Tshwane, South Africa.
    Wechsberg WM; Browne FA; Ndirangu J; Bonner CP; Minnis AM; Nyblade L; Speizer IS; Howard BN; Myers B; Ahmed K
    BMC Public Health; 2020 Sep; 20(1):1403. PubMed ID: 32933510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent girls and young women's PrEP-user journey during an implementation science study in South Africa and Kenya.
    Rousseau E; Katz AWK; O'Rourke S; Bekker LG; Delany-Moretlwe S; Bukusi E; Travill D; Omollo V; Morton JF; O'Malley G; Haberer JE; Heffron R; Johnson R; Celum C; Baeten JM; van der Straten A
    PLoS One; 2021; 16(10):e0258542. PubMed ID: 34648589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa.
    Beesham I; Milford C; Smit J; Joseph Davey DL; Baeten JM; Heffron R; Beksinska M; Mansoor LE
    BMC Public Health; 2023 Jun; 23(1):1210. PubMed ID: 37349816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.
    Rousseau E; Sikkema KJ; Julies RF; Mazer K; O'Malley G; Heffron R; Morton JF; Johnson R; Celum C; Baeten JM; Bekker LG
    J Int AIDS Soc; 2024 May; 27(5):e26254. PubMed ID: 38695101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How gender norms and 'good girl' notions prevent adolescent girls and young women from engaging with PrEP: qualitative insights from Zimbabwe.
    Skovdal M; Clausen CL; Magoge-Mandizvidza P; Dzamatira F; Maswera R; Nyamwanza RP; Nyamukapa C; Thomas R; Gregson S
    BMC Womens Health; 2022 Aug; 22(1):344. PubMed ID: 35974360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.